BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Prideaux L, Kamm MA, De Cruz PP, Chan FK, Ng SC. Inflammatory bowel disease in Asia: a systematic review. J Gastroenterol Hepatol 2012;27:1266-80. [PMID: 22497584 DOI: 10.1111/j.1440-1746.2012.07150.x] [Cited by in Crossref: 195] [Cited by in F6Publishing: 196] [Article Influence: 19.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang CD, Guo XX. Goal of treatment of inflammatory bowel disease: Deep remission and therapeutic strategies. Shijie Huaren Xiaohua Zazhi 2015; 23(24): 3824-3830 [DOI: 10.11569/wcjd.v23.i24.3824] [Reference Citation Analysis]
2 Shah A, Talley NJ, Walker M, Koloski N, Morrison M, Burger D, Andrews JM, Mcguckin M, Jones M, Holtmann G. Is There a Link Between H. Pylori and the Epidemiology of Crohn’s Disease? Dig Dis Sci 2017;62:2472-80. [DOI: 10.1007/s10620-017-4496-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
3 Yao P, Cui M, Wang H, Gao H, Wang L, Yang T, Cheng Y. Quantitative Analysis of Intestinal Flora of Uygur and Han Ethnic Chinese Patients with Ulcerative Colitis. Gastroenterol Res Pract 2016;2016:9186232. [PMID: 26839545 DOI: 10.1155/2016/9186232] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
4 Zhang T, Hong L, Wang Z, Fan R, Zhang M, Lin Y, Cheng M, Zhou X, Sun P, Lin X, Zhong J. Comparison between Intestinal Behçet's Disease and Crohn's Disease in Characteristics of Symptom, Endoscopy, and Radiology. Gastroenterol Res Pract 2017;2017:3918746. [PMID: 28642788 DOI: 10.1155/2017/3918746] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
5 Riansuwan W, Limsrivilai J. Current status of IBD and surgery of Crohn's disease in Thailand. Ann Gastroenterol Surg 2021;5:597-603. [PMID: 34585044 DOI: 10.1002/ags3.12470] [Reference Citation Analysis]
6 Zhai H, Liu A, Huang W, Liu X, Feng S, Wu J, Yao Y, Wang C, Li Q, Hao Q, Hu J, Zhang S. Increasing rate of inflammatory bowel disease: a 12-year retrospective study in NingXia, China. BMC Gastroenterol 2016;16:2. [PMID: 26754840 DOI: 10.1186/s12876-015-0405-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
7 Zhang R, Liu WT. Important effect of micronutrient deficiency in inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2016; 24(22): 3354-3361 [DOI: 10.11569/wcjd.v24.i22.3354] [Reference Citation Analysis]
8 Yang Y, Xiang L, He J. Beverage intake and risk of Crohn disease: A meta-analysis of 16 epidemiological studies. Medicine (Baltimore) 2019;98:e15795. [PMID: 31124976 DOI: 10.1097/MD.0000000000015795] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
9 Burisch J, Munkholm P. Inflammatory bowel disease epidemiology. Curr Opin Gastroenterol. 2013;29:357-362. [PMID: 23695429 DOI: 10.1097/mog.0b013e32836229fb] [Cited by in Crossref: 99] [Cited by in F6Publishing: 54] [Article Influence: 12.4] [Reference Citation Analysis]
10 Coppell KJ, Galts CP, Huizing FY, Norton JK, Gray AR, Schultz K, Hobbs CE, Aluzaite K, Schultz M. Annual Incidence and Phenotypic Presentation of IBD in Southern New Zealand: An 18-Year Epidemiological Analysis. Inflamm Intest Dis 2018;3:32-9. [PMID: 30505840 DOI: 10.1159/000492615] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
11 Pratap Mouli V, Munot K, Ananthakrishnan A, Kedia S, Addagalla S, Garg SK, Benjamin J, Singla V, Dhingra R, Tiwari V, Bopanna S, Hutfless S, Makharia G, Ahuja V. Endoscopic and clinical responses to anti-tubercular therapy can differentiate intestinal tuberculosis from Crohn's disease. Aliment Pharmacol Ther. 2017;45:27-36. [PMID: 27813111 DOI: 10.1111/apt.13840] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 6.7] [Reference Citation Analysis]
12 Kondamudi PK, Malayandi R, Eaga C, Aggarwal D. Drugs as causative agents and therapeutic agents in inflammatory bowel disease. Acta Pharmaceutica Sinica B 2013;3:289-96. [DOI: 10.1016/j.apsb.2013.06.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
13 Yang Y, Tomkovich S, Jobin C. Could a swimming creature inform us on intestinal diseases? Lessons from zebrafish. Inflamm Bowel Dis 2014;20:956-66. [PMID: 24577115 DOI: 10.1097/01.MIB.0000442923.85569.68] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
14 Wen J, Yang P, Chen X, Fang Y, Chang Q, Li C, Zhang C. The role of Th17/Treg balance and Th22 cell in the pathogenesis of DSS-induced colitis in mice. Eur J Inflamm 2015;13:101-8. [DOI: 10.1177/1721727x15580902] [Cited by in Crossref: 4] [Article Influence: 0.6] [Reference Citation Analysis]
15 Song HK, Lee KM, Jung SA, Hong SN, Han DS, Yang SK; IBD study group of Korean Association for the Study of Intestinal Diseases (KASID). Quality of care in inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2(nd) Asian Organization of Crohn's and Colitis (AOCC) meeting in Seoul. Intest Res 2016;14:240-7. [PMID: 27433146 DOI: 10.5217/ir.2016.14.3.240] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
16 Ruokolainen L, Paalanen L, Karkman A, Laatikainen T, von Hertzen L, Vlasoff T, Markelova O, Masyuk V, Auvinen P, Paulin L, Alenius H, Fyhrquist N, Hanski I, Mäkelä MJ, Zilber E, Jousilahti P, Vartiainen E, Haahtela T. Significant disparities in allergy prevalence and microbiota between the young people in Finnish and Russian Karelia. Clin Exp Allergy 2017;47:665-74. [PMID: 28165640 DOI: 10.1111/cea.12895] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 10.8] [Reference Citation Analysis]
17 Periasamy S, Lin CH, Nagarajan B, Sankaranarayanan NV, Desai UR, Liu MY. Mucoadhesive role of tamarind xyloglucan on inflammation attenuates ulcerative colitis. J Funct Foods 2018;47:1-10. [PMID: 30555535 DOI: 10.1016/j.jff.2018.05.035] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
18 Paudel MS, Khanal A, Shrestha B, Purbey B, Paudel BN, Shrestha G, Thapa J, Dewan KR, Gurung R, Joshi N. Epidemiology of Inflammatory Bowel Diseases in Nepal. Cureus 2021;13:e16692. [PMID: 34466323 DOI: 10.7759/cureus.16692] [Reference Citation Analysis]
19 Ali RA. The positive influences of increasing age at diagnosis of inflammatory bowel disease on disease prognostication in asian perspective. Intest Res 2015;13:4-5. [PMID: 25691837 DOI: 10.5217/ir.2015.13.1.4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
20 Lui RNS, Ng SC. The Same Intestinal Inflammatory Disease despite Different Genetic Risk Factors in the East and West? Inflamm Intest Dis 2016;1:78-84. [PMID: 29922661 DOI: 10.1159/000446625] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
21 Ooi CJ, Hilmi IN, Kim HJ, Jalihal U, Wu DC, Demuth D, Lindner D, Adsul S. Efficacy and safety of vedolizumab in ulcerative colitis in patients from Asian countries in the GEMINI 1 study. Intest Res 2021;19:71-82. [PMID: 32877600 DOI: 10.5217/ir.2019.09159] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Xu L, Huang G, Cong Y, Yu Y, Li Y. Sex-related Differences in Inflammatory Bowel Diseases: The Potential Role of Sex Hormones. Inflamm Bowel Dis 2022:izac094. [PMID: 35486387 DOI: 10.1093/ibd/izac094] [Reference Citation Analysis]
23 Steegenga WT, Mischke M, Lute C, Boekschoten MV, Pruis MG, Lendvai A, Verkade HJ, Boekhorst J, Timmerman HM, Plösch T, Müller M. Sexually dimorphic characteristics of the small intestine and colon of prepubescent C57BL/6 mice. Biol Sex Differ 2014;5:11. [PMID: 25243059 DOI: 10.1186/s13293-014-0011-9] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 5.4] [Reference Citation Analysis]
24 Su HJ, Chiu YT, Chiu CT, Lin YC, Wang CY, Hsieh JY, Wei SC. Inflammatory bowel disease and its treatment in 2018: Global and Taiwanese status updates. J Formos Med Assoc. 2019;118:1083-1092. [PMID: 30054112 DOI: 10.1016/j.jfma.2018.07.005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 6.8] [Reference Citation Analysis]
25 Su HY, Gupta V, Day AS, Gearry RB. Rising Incidence of Inflammatory Bowel Disease in Canterbury, New Zealand. Inflamm Bowel Dis. 2016;22:2238-2244. [PMID: 27482976 DOI: 10.1097/mib.0000000000000829] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
26 Yu HC, Chen TP, Chang YC. Inflammatory bowel disease as a risk factor for periodontitis under Taiwanese National Health Insurance Research database. J Dent Sci 2018;13:242-7. [PMID: 30895127 DOI: 10.1016/j.jds.2018.03.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
27 Kayar Y, Dertli R, Konur S, Agin M, Baran B, Ormeci AC, Akyuz F, Demir K, Besisik F, Kaymakoglu S. The development of extraintestinal manifestation and related risk factors in Crohn's patients. Ir J Med Sci 2021;190:597-604. [PMID: 32748219 DOI: 10.1007/s11845-020-02326-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Yamamoto T. Nutrition and diet in inflammatory bowel disease. Curr Opin Gastroenterol. 2013;29:216-221. [PMID: 23385526 DOI: 10.1097/mog.0b013e32835b9a40] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
29 Yang H, Li Y, Wu W, Sun Q, Zhang Y, Zhao W, Lv H, Xia Q, Hu P, Li H, Qian J. The incidence of inflammatory bowel disease in Northern China: a prospective population-based study. PLoS One. 2014;9:e101296. [PMID: 25029440 DOI: 10.1371/journal.pone.0101296] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 5.4] [Reference Citation Analysis]
30 Troncoso LL, Biancardi AL, de Moraes Jr HV, Zaltman C. Ophthalmic manifestations in patients with inflammatory bowel disease: A review. World J Gastroenterol 2017; 23(32): 5836-5848 [PMID: 28932076 DOI: 10.3748/wjg.v23.i32.5836] [Cited by in CrossRef: 48] [Cited by in F6Publishing: 25] [Article Influence: 9.6] [Reference Citation Analysis]
31 Wu XR, Liu HS, Shi XY, Zhou WX, Jiang ZN, Huang Y, Karamchandani DM, Goldblum JR, Xiao SY, Zhu HF, Feely MM, Collinsworth AL, Esnakula A, Xie H, Shen B, Lan P, Liu XL. Interobserver Agreement in the Diagnosis of Inflammatory Bowel Disease-Associated Neoplasia in China in Comparison to Subspecialized American Gastrointestinal Pathologists. Gastroenterol Res Pract 2018;2018:8715263. [PMID: 29849600 DOI: 10.1155/2018/8715263] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
32 Hanzel J, Ma C, Casteele NV, Khanna R, Jairath V, Feagan BG. Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease. Drugs 2021;81:333-47. [PMID: 33400241 DOI: 10.1007/s40265-020-01460-3] [Reference Citation Analysis]
33 Parente JML, Coy CSR, Campelo V, Parente MPPD, Costa LA, Silva RMD, Stephan C, Zeitune JMR. Inflammatory bowel disease in an underdeveloped region of Northeastern Brazil. World J Gastroenterol 2015; 21(4): 1197-1206 [PMID: 25632193 DOI: 10.3748/wjg.v21.i4.1197] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 35] [Article Influence: 5.6] [Reference Citation Analysis]
34 Lim H, Kim HJ, Hong SJ, Kim S. Nutrient intake and bone mineral density by nutritional status in patients with inflammatory bowel disease. J Bone Metab. 2014;21:195-203. [PMID: 25247157 DOI: 10.11005/jbm.2014.21.3.195] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
35 Young Cho J, Yeon Kim H, Me Kim H, Na Song H, Hong E, Hwang J, Sook Chun H. Standardized ethanolic extract of the rhizome of Curcuma xanthorrhiza prevents murine ulcerative colitis by regulation of inflammation. Journal of Functional Foods 2017;30:282-9. [DOI: 10.1016/j.jff.2017.01.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
36 Zhang W, Michalowski CB, Beloqui A. Oral Delivery of Biologics in Inflammatory Bowel Disease Treatment. Front Bioeng Biotechnol 2021;9:675194. [PMID: 34150733 DOI: 10.3389/fbioe.2021.675194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Brunet E, Roig-Ramos C, Vela E, Clèries M, Melcarne L, Villòria A, Pontes C, Calvet X. Prevalence, incidence and mortality of inflammatory bowel disease in Catalonia. A population-based analysis. Ann Med 2018;50:613-9. [PMID: 30247071 DOI: 10.1080/07853890.2018.1523550] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
38 Eszter Müller K, Laszlo Lakatos P, Papp M, Veres G. Incidence and paris classification of pediatric inflammatory bowel disease. Gastroenterol Res Pract 2014;2014:904307. [PMID: 24778643 DOI: 10.1155/2014/904307] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
39 Qiu T, Li H, Sun T, Men P, Cui X, Liu C, Zhai S. Thalidomide as a treatment for inflammatory bowel disease in children and adolescents: A systematic review. J Clin Pharm Ther 2020;45:1134-42. [DOI: 10.1111/jcpt.13196] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 Jeon M, Song K, Koo J, Kim S. Evaluation of a Seton Procedure Combined With Infliximab Therapy (Early vs. Late) in Perianal Fistula With Crohn Disease. Ann Coloproctol. 2019;35:249-253. [PMID: 31726000 DOI: 10.3393/ac.2018.11.23.1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
41 Prideaux L, Kang S, Wagner J, Buckley M, Mahar JE, De Cruz P, Wen Z, Chen L, Xia B, van Langenberg DR. Impact of ethnicity, geography, and disease on the microbiota in health and inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:2906-2918. [PMID: 24240708 DOI: 10.1097/01.mib.0000435759.05577.12] [Cited by in Crossref: 54] [Cited by in F6Publishing: 30] [Article Influence: 6.8] [Reference Citation Analysis]
42 Lu J, Dong B, Chen A, He F, Peng B, Wu Z, Cao J, Li W. Escherichia coli promotes DSS‑induced murine colitis recovery through activation of the TLR4/NF‑κB signaling pathway. Mol Med Rep 2019;19:2021-8. [PMID: 30664156 DOI: 10.3892/mmr.2019.9848] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
43 Ng SC, Zeng Z, Niewiadomski O, Tang W, Bell S, Kamm MA, Hu P, de Silva HJ, Niriella MA, Udara WS. Early Course of Inflammatory Bowel Disease in a Population-Based Inception Cohort Study From 8 Countries in Asia and Australia. Gastroenterology. 2016;150:86-95.e3; quiz e13-4. [PMID: 26385074 DOI: 10.1053/j.gastro.2015.09.005] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 9.1] [Reference Citation Analysis]
44 Abdulla M, Al Saeed M, Fardan RH, Alalwan HF, Ali Almosawi ZS, Almahroos AF, Al Qamish J. Inflammatory bowel disease in Bahrain: single-center experience. Clin Exp Gastroenterol 2017;10:133-45. [PMID: 28765713 DOI: 10.2147/CEG.S127909] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
45 Ghosh S, Almadi MA. Inflammatory bowel disease: a global disease. Saudi J Gastroenterol 2013;19:1-2. [PMID: 23319031 DOI: 10.4103/1319-3767.105905] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
46 Hibi T, Motoya S, Ashida T, Sai S, Sameshima Y, Nakamura S, Maemoto A, Nii M, Sullivan BA, Gasser RA Jr, Suzuki Y. Efficacy and safety of abrilumab, an α4β7 integrin inhibitor, in Japanese patients with moderate-to-severe ulcerative colitis: a phase II study. Intest Res 2019;17:375-86. [PMID: 30739435 DOI: 10.5217/ir.2018.00141] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
47 Chang CW, Wong JM, Tung CC, Shih IL, Wang HY, Wei SC. Intestinal stricture in Crohn’s disease. Intest Res. 2015;13:19-26. [PMID: 25691840 DOI: 10.5217/ir.2015.13.1.19] [Cited by in Crossref: 48] [Cited by in F6Publishing: 32] [Article Influence: 6.9] [Reference Citation Analysis]
48 Yang SK, Hong M, Choi H, Zhao W, Jung Y, Haritunians T, Ye BD, Kim KJ, Park SH, Lee I, Kim WH, Cheon JH, Kim YH, Jang BI, Kim HS, Choi JH, Koo JS, Lee JH, Jung SA, Shin HD, Kang D, Youn HS, Taylor KD, Rotter JI, Liu J, McGovern DP, Song K. Immunochip analysis identification of 6 additional susceptibility loci for Crohn's disease in Koreans. Inflamm Bowel Dis 2015;21:1-7. [PMID: 25489960 DOI: 10.1097/MIB.0000000000000268] [Cited by in Crossref: 36] [Cited by in F6Publishing: 23] [Article Influence: 5.1] [Reference Citation Analysis]
49 Kohashi M, Nishiumi S, Ooi M, Yoshie T, Matsubara A, Suzuki M, Hoshi N, Kamikozuru K, Yokoyama Y, Fukunaga K, Nakamura S, Azuma T, Yoshida M. A novel gas chromatography mass spectrometry-based serum diagnostic and assessment approach to ulcerative colitis. J Crohns Colitis 2014;8:1010-21. [DOI: 10.1016/j.crohns.2014.01.024] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
50 Ashton JJ, Ennis S, Beattie RM. Early-onset paediatric inflammatory bowel disease. The Lancet Child & Adolescent Health 2017;1:147-58. [DOI: 10.1016/s2352-4642(17)30017-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 2.6] [Reference Citation Analysis]
51 Piotrowska M, Swierczynski M, Fichna J, Piechota-Polanczyk A. The Nrf2 in the pathophysiology of the intestine: Molecular mechanisms and therapeutic implications for inflammatory bowel diseases. Pharmacol Res 2021;163:105243. [PMID: 33080322 DOI: 10.1016/j.phrs.2020.105243] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
52 Shepherd C, Wangchuk P, Loukas A. Of dogs and hookworms: man's best friend and his parasites as a model for translational biomedical research. Parasit Vectors 2018;11:59. [PMID: 29370855 DOI: 10.1186/s13071-018-2621-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
53 Prudhviraj G, Vaidya Y, Singh SK, Yadav AK, Kaur P, Gulati M, Gowthamarajan K. Effect of co-administration of probiotics with polysaccharide based colon targeted delivery systems to optimize site specific drug release. European Journal of Pharmaceutics and Biopharmaceutics 2015;97:164-72. [DOI: 10.1016/j.ejpb.2015.09.012] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
54 Ko MK, Ng SC, Mak L, Li MK, Lo FH, Ng CKM, Lao WC, Tsang S, Chan KH, Hui YT, Shan EHS, Loo CK, Hui AJ, To WP, Hung IF, Leung WK. Infection-related hospitalizations in the first year after inflammatory bowel disease diagnosis: Infection in new IBD patients. Journal of Digestive Diseases 2016;17:610-7. [DOI: 10.1111/1751-2980.12397] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
55 Ng SC. Epidemiology of inflammatory bowel disease: focus on Asia. Best Pract Res Clin Gastroenterol. 2014;28:363-372. [PMID: 24913377 DOI: 10.1016/j.bpg.2014.04.003] [Cited by in Crossref: 85] [Cited by in F6Publishing: 80] [Article Influence: 10.6] [Reference Citation Analysis]
56 Krishna MT, Mahesh PA, Vedanthan P, Moitra S, Mehta V, Christopher DJ. An appraisal of allergic disorders in India and an urgent call for action. World Allergy Organ J 2020;13:100446. [PMID: 32774662 DOI: 10.1016/j.waojou.2020.100446] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
57 Chivese T, Esterhuizen TM, Basson AR, Watermeyer G. The Influence of Second-Hand Cigarette Smoke Exposure during Childhood and Active Cigarette Smoking on Crohn's Disease Phenotype Defined by the Montreal Classification Scheme in a Western Cape Population, South Africa. PLoS One 2015;10:e0139597. [PMID: 26422615 DOI: 10.1371/journal.pone.0139597] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
58 Makhani N, Morrow S, Fisk J, Evans C, Beland S, Kulaga S, Kingwell E, Marriott J, Dykeman J, Jetté N, Pringsheim T, Wolfson C, Marrie R, Koch M. MS incidence and prevalence in Africa, Asia, Australia and New Zealand: A systematic review. Multiple Sclerosis and Related Disorders 2014;3:48-60. [DOI: 10.1016/j.msard.2013.06.015] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
59 Wei SC, Chang TA, Chao TH, Chen JS, Chou JW, Chou YH, Chuang CH, Hsu WH, Huang TY, Hsu TC, Lin CC, Lin HH, Lin JK, Lin WC, Ni YH, Shieh MJ, Shih IL, Shun CT, Tsang YM, Wang CY, Wang HY, Weng MT, Wu DC, Wu WC, Yen HH, Wong JM. Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease. Intest Res 2017;15:285-310. [PMID: 28670226 DOI: 10.5217/ir.2017.15.3.285] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
60 Halmos EP, Gibson PR. Dietary management of IBD--insights and advice. Nat Rev Gastroenterol Hepatol. 2015;12:133-146. [PMID: 25645969 DOI: 10.1038/nrgastro.2015.11] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 6.7] [Reference Citation Analysis]
61 Ng SC. Emerging leadership lecture: Inflammatory bowel disease in Asia: Emergence of a “Western” disease: IBD in Asia. J Gastroenterol Hepatol 2015;30:440-5. [DOI: 10.1111/jgh.12859] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 8.6] [Reference Citation Analysis]
62 Tseng CC, Yen JH, Tsai WC, Ou TT, Wu CC, Sung WY, Hsieh MC, Chang SJ. Reduced incidence of Crohn's disease in systemic sclerosis: a nationwide population study. BMC Musculoskelet Disord 2015;16:251. [PMID: 26370572 DOI: 10.1186/s12891-015-0693-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
63 Saleem A, Zeeshan M, Hazoor F, Mustafa G. Sigmoidoscopic extent of ulcerative colitis and associated factors in Pakistani population. Pak J Med Sci 2022;38:276-80. [PMID: 35035439 DOI: 10.12669/pjms.38.1.4648] [Reference Citation Analysis]
64 Alhagamhmad MH, Lemberg DA, Day AS, Tan L, Ooi CY, Krishnan U, Gupta N, Munday JS, Leach ST. Advancing nutritional therapy: A novel polymeric formulation attenuates intestinal inflammation in a murine colitis model and suppresses pro-inflammatory cytokine production in ex-vivo cultured inflamed colonic biopsies. Clinical Nutrition 2017;36:497-505. [DOI: 10.1016/j.clnu.2016.01.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
65 Barash Y, Klang E, Tau N, Ben-Horin S, Mahajna H, Levartovsky A, Arebi N, Soffer S, Kopylov U. Evolution of Inflammatory Bowel Disease Research From a Bird's-Eye Perspective: A Text-Mining Analysis of Publication Trends and Topics. Inflamm Bowel Dis 2021;27:434-9. [PMID: 32440691 DOI: 10.1093/ibd/izaa091] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
66 Sharma U, Olson RK, Erhart FN, Zhang L, Meng J, Segura B, Banerjee S, Sharma M, Saluja AK, Ramakrishnan S, Abreu MT, Roy S. Prescription Opioids induce Gut Dysbiosis and Exacerbate Colitis in a Murine Model of Inflammatory Bowel Disease. J Crohns Colitis 2020;14:801-17. [PMID: 31773170 DOI: 10.1093/ecco-jcc/jjz188] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
67 Chou JW, Lai HC, Chang CH, Cheng KS, Feng CL, Chen TW. Epidemiology and Clinical Outcomes of Inflammatory Bowel Disease: A Hospital-Based Study in Central Taiwan. Gastroenterol Res Pract. 2019;2019:4175923. [PMID: 31312216 DOI: 10.1155/2019/4175923] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
68 Jain M, Venkataraman J. Inflammatory bowel disease: An Indian perspective. Indian J Med Res 2021;153:421-30. [PMID: 34380788 DOI: 10.4103/ijmr.IJMR_936_18] [Reference Citation Analysis]
69 de Barros KSC, Flores C, Harlacher L, Francesconi CFM. Evolution of Clinical Behavior in Crohn's Disease: Factors Associated with Complicated Disease and Surgery. Dig Dis Sci 2017;62:2481-8. [PMID: 28748409 DOI: 10.1007/s10620-017-4685-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
70 Gearry RB, Leong RW. Inflammatory bowel disease in Asia: The start of the epidemic?: Editorial. J Gastroenterol Hepatol 2013;28:899-900. [DOI: 10.1111/jgh.12218] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
71 Ha JE, Jang EJ, Im SG, Sohn HS. Medication Use and Drug Expenditure in Inflammatory Bowel Disease: based on Korean National Health Insurance Claims Data (2010-2014). Korean J Clin Pharm 2019;29:79-88. [DOI: 10.24304/kjcp.2019.29.2.79] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
72 Jung YS, Han M, Kim WH, Park S, Cheon JH. Incidence and Clinical Outcomes of Inflammatory Bowel Disease in South Korea, 2011-2014: A Nationwide Population-Based Study. Dig Dis Sci. 2017;62:2102-2112. [PMID: 28593437 DOI: 10.1007/s10620-017-4640-9] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 6.8] [Reference Citation Analysis]
73 Roda G, Chien Ng S, Kotze PG, Argollo M, Panaccione R, Spinelli A, Kaser A, Peyrin-Biroulet L, Danese S. Crohn's disease.Nat Rev Dis Primers. 2020;6:22. [PMID: 32242028 DOI: 10.1038/s41572-020-0156-2] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 23.5] [Reference Citation Analysis]
74 Nguyen GC, Chong CA, Chong RY. National estimates of the burden of inflammatory bowel disease among racial and ethnic groups in the United States. Journal of Crohn's and Colitis 2014;8:288-95. [DOI: 10.1016/j.crohns.2013.09.001] [Cited by in Crossref: 79] [Cited by in F6Publishing: 76] [Article Influence: 9.9] [Reference Citation Analysis]
75 Xu J, Tang M, Shen J. Trends and Factors Affecting Hospitalization Costs in Patients with Inflammatory Bowel Disease: A Two-Center Study over the Past Decade. Gastroenterol Res Pract 2013;2013:267630. [PMID: 24307891 DOI: 10.1155/2013/267630] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
76 Singh P, Ananthakrishnan A, Ahuja V. Pivot to Asia: inflammatory bowel disease burden. Intest Res. 2017;15:138-141. [PMID: 28239326 DOI: 10.5217/ir.2017.15.1.138] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 7.8] [Reference Citation Analysis]
77 Nie JY, Zhao Q. Beverage consumption and risk of ulcerative colitis: Systematic review and meta-analysis of epidemiological studies. Medicine (Baltimore) 2017;96:e9070. [PMID: 29245319 DOI: 10.1097/MD.0000000000009070] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 5.3] [Reference Citation Analysis]
78 Liu H, Liu W, Huang X, Feng Y, Lu J, Gao F. Intestinal flora differences between patients with ulcerative colitis of different ethnic groups in China. Medicine (Baltimore) 2021;100:e26932. [PMID: 34397940 DOI: 10.1097/MD.0000000000026932] [Reference Citation Analysis]
79 Hossen I, Hua W, Ting L, Mehmood A, Jingyi S, Duoxia X, Yanping C, Hongqing W, Zhipeng G, Kaiqi Z, Fang Y, Junsong X. Phytochemicals and inflammatory bowel disease: a review. Crit Rev Food Sci Nutr 2020;60:1321-45. [PMID: 30729797 DOI: 10.1080/10408398.2019.1570913] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 7.7] [Reference Citation Analysis]
80 Ng WK, Wong SH, Ng SC. Changing epidemiological trends of inflammatory bowel disease in Asia. Intest Res. 2016;14:111-119. [PMID: 27175111 DOI: 10.5217/ir.2016.14.2.111] [Cited by in Crossref: 159] [Cited by in F6Publishing: 150] [Article Influence: 26.5] [Reference Citation Analysis]
81 Zhou Y, Huang Y. Inflammatory bowel disease in Chinese children: A retrospective analysis of 49 cases. Exp Ther Med 2016;12:3363-8. [PMID: 27882164 DOI: 10.3892/etm.2016.3756] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
82 Masaki T, Kishiki T, Kojima K, Asou N, Beniya A, Matsuoka H. Recent trends (2016-2017) in the treatment of inflammatory bowel disease. Ann Gastroenterol Surg 2018;2:282-8. [PMID: 30003191 DOI: 10.1002/ags3.12177] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
83 Kim JY, Park DI, Han DS, Huh KC, Lee CK, Shin JE, Kim JH, Kim YS, Jung Y, Jung SA, Song HJ, Jang HJ, Kim YH, Hong SN. Comparing the clinical outcomes of young-onset and adult-onset ulcerative colitis: a multi-center Korean Association for the Study for Intestinal Diseases study. Korean J Intern Med 2017;32:69-78. [PMID: 27338135 DOI: 10.3904/kjim.2014.262] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
84 Li LQ, Zeng J, Wang S, Chen X, Jiang Z. Fecal calprotectin for diagnosis of inflammatory bowel disease: A meta-analysis. Shijie Huaren Xiaohua Zazhi 2016; 24(31): 4272-4278 [DOI: 10.11569/wcjd.v24.i31.4272] [Reference Citation Analysis]
85 Carroll MW, Hamilton Z, Gill H, Simkin J, Smyth M, Espinosa V, Bressler B, Jacobson K. Pediatric Inflammatory Bowel Disease Among South Asians Living in British Columbia, Canada: A Distinct Clinical Phenotype. Inflammatory Bowel Diseases 2016;22:387-96. [DOI: 10.1097/mib.0000000000000651] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
86 Liu B, Piao X, Guo L, Wang G, Sun W, Gao L, Zheng X, Fang Y. A New Chinese Medicine Intestine Formula Greatly Improves the Effect of Aminosalicylate on Ulcerative Colitis. Evid Based Complement Alternat Med. 2017;2017:7323129. [PMID: 29358969 DOI: 10.1155/2017/7323129] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
87 Zhang T, Kayani MUR, Hong L, Zhang C, Zhong J, Wang Z, Chen L. Dynamics of the Salivary Microbiome During Different Phases of Crohn's Disease. Front Cell Infect Microbiol 2020;10:544704. [PMID: 33123492 DOI: 10.3389/fcimb.2020.544704] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
88 Niriella MA, Liyanage IK, Kodisinghe SK, Silva APD, Rajapakshe N, Nanayakkara SD, Luke D, Silva T, Nawarathne M, Peiris RK, Kalubovila UP, Kumarasena SR, Dissanayake VHW, Jayasekara RW, de Silva HJ. Genetic associations of inflammatory bowel disease in a South Asian population. World J Clin Cases 2018; 6(15): 908-915 [PMID: 30568945 DOI: 10.12998/wjcc.v6.i15.908] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
89 Farkas K, Chan H, Rutka M, Szepes Z, Nagy F, Tiszlavicz L, Nyári T, Tang W, Wong G, Tang R, Lo A, Cheung C, Wong S, Lui R, Molnár T, Ng SC. Gastroduodenal Involvement in Asymptomatic Crohn’s Disease Patients in Two Areas of Emerging Disease: Asia and Eastern Europe. ECCOJC 2016;10:1401-6. [DOI: 10.1093/ecco-jcc/jjw113] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
90 Yang X, Geng J, Meng H. Glucocorticoid receptor modulates dendritic cell function in ulcerative colitis. Histol Histopathol 2020;35:1379-89. [PMID: 32706033 DOI: 10.14670/HH-18-241] [Reference Citation Analysis]
91 Racine A, Carbonnel F, Chan SS, Hart AR, Bueno-de-Mesquita HB, Oldenburg B, van Schaik FD, Tjønneland A, Olsen A, Dahm CC. Dietary Patterns and Risk of Inflammatory Bowel Disease in Europe: Results from the EPIC Study. Inflamm Bowel Dis. 2016;22:345-354. [PMID: 26717318 DOI: 10.1097/mib.0000000000000638] [Cited by in Crossref: 114] [Cited by in F6Publishing: 47] [Article Influence: 19.0] [Reference Citation Analysis]
92 Xiong Y, Lou Y, Su H, Fu Y, Kong J. Cholecalciterol cholesterol emulsion ameliorates experimental colitis via down-regulating the pyroptosis signaling pathway. Exp Mol Pathol. 2016;100:386-392. [PMID: 26970278 DOI: 10.1016/j.yexmp.2016.03.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
93 Mokhtar NM, Nawawi KNM, Verasingam J, Zhiqin W, Sagap I, Azman ZAM, Mazlan L, Hamid HA, Yaacob NY, Rose IM, Den ELN, Wan MS, Raja Ali RA. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia. BMC Public Health 2019;19:550. [PMID: 31196184 DOI: 10.1186/s12889-019-6858-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
94 Abdul Rani R, Raja Ali RA, Lee YY. Irritable bowel syndrome and inflammatory bowel disease overlap syndrome: pieces of the puzzle are falling into place. Intest Res 2016;14:297-304. [PMID: 27799880 DOI: 10.5217/ir.2016.14.4.297] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
95 So J, Tang W, Leung WK, Li M, Lo FH, Wong MTL, Sze ASF, Leung CM, Tsang SWC, Shan EHS, Chan KH, Lam BCY, Hui AJ, Chow WH, Lam TY, Lam V, Lee TW, Lo HHH, Tang CM, Wong CL, Wu JCY, Chan FKL, Sung JJY, Harbord M, Ng SC. Cancer Risk in 2621 Chinese Patients with Inflammatory Bowel Disease: A Population-based Cohort Study. Inflamm Bowel Dis 2017;23:2061-8. [PMID: 28991855 DOI: 10.1097/MIB.0000000000001240] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
96 Asthana AK, Friedman AB, Maconi G, Maaser C, Kucharzik T, Watanabe M, Gibson PR. Failure of gastroenterologists to apply intestinal ultrasound in inflammatory bowel disease in the Asia-Pacific: a need for action. J Gastroenterol Hepatol. 2015;30:446-452. [PMID: 25529767 DOI: 10.1111/jgh.12871] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.1] [Reference Citation Analysis]
97 Wu WKK, Sun R, Zuo T, Tian Y, Zeng Z, Ho J, Wu JCY, Chan FKL, Chan MTV, Yu J, Sung JJY, Wong SH, Wang MH, Ng SC. A novel susceptibility locus in MST1 and gene-gene interaction network for Crohn's disease in the Chinese population. J Cell Mol Med 2018;22:2368-77. [PMID: 29441677 DOI: 10.1111/jcmm.13530] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
98 Shepherd C, Navarro S, Wangchuk P, Wilson D, Daly NL, Loukas A. Identifying the immunomodulatory components of helminths. Parasite Immunol 2015;37:293-303. [PMID: 25854639 DOI: 10.1111/pim.12192] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 6.0] [Reference Citation Analysis]
99 Zhang T, Wang Z, Fan R, Zhang M, Lin Y, Hong L, Zhou X, Hu S, Cheng M, Zhong J. The Efficacy of Infliximab Monotherapy versus Infliximab-Azathioprine Sequential Treatment in Crohn's Disease: Experience from a Tertiary Medical Center in China. Biomed Res Int 2016;2016:8648307. [PMID: 27896276 DOI: 10.1155/2016/8648307] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
100 Kuo CJ, Yu KH, See LC, Chiu CT, Su MY, Hsu CM, Kuo CF, Chiou MJ, Liu JR, Wang HW. The Trend of Inflammatory Bowel Diseases in Taiwan: A Population-Based Study. Dig Dis Sci. 2015;60:2454-2462. [PMID: 25837597 DOI: 10.1007/s10620-015-3630-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 3.1] [Reference Citation Analysis]
101 Wang G, Xu Q, Jin X, Hang F, Liu Z, Zhao J, Zhang H, Chen W. Effects of lactobacilli with different regulatory behaviours on tight junctions in mice with dextran sodium sulphate-induced colitis. Journal of Functional Foods 2018;47:107-15. [DOI: 10.1016/j.jff.2018.05.044] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
102 Devlin SM, Bressler B, Bernstein CN, Fedorak RN, Bitton A, Singh H, Feagan BG. Overview of subsequent entry biologics for the management of inflammatory bowel disease and Canadian Association of Gastroenterology position statement on subsequent entry biologics. Can J Gastroenterol 2013;27:567-71. [PMID: 24106727 DOI: 10.1155/2013/327120] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
103 Wang Y, Tang Q, Duan P, Yang L. Curcumin as a therapeutic agent for blocking NF-κB activation in ulcerative colitis. Immunopharmacol Immunotoxicol 2018;40:476-82. [PMID: 30111198 DOI: 10.1080/08923973.2018.1469145] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
104 Kashyap PC, Reigstad CS, Loftus EV Jr. Role of diet and gut microbiota in management of inflammatory bowel disease in an Asian migrant. J Allergy Clin Immunol 2013;132:250-250.e5. [PMID: 23810100 DOI: 10.1016/j.jaci.2013.05.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
105 Magrì S, Paduano D, Chicco F, Cingolani A, Farris C, Delogu G, Tumbarello F, Lai M, Melis A, Casula L, Fantini MC, Usai P. Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history. World J Gastroenterol 2019; 25(37): 5676-5686 [PMID: 31602167 DOI: 10.3748/wjg.v25.i37.5676] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
106 Hiratsuka T, Inomata M, Goto S, Oyama Y, Nakano T, Chen C, Shiraishi N, Noguchi T, Kitano S. Phototherapy with artificial light suppresses dextran sulfate sodium-induced colitis in a mouse model: Phototherapy on DSS colitis. J Gastroenterol Hepatol 2014;29:749-56. [DOI: 10.1111/jgh.12460] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
107 Yang Y, Jobin C. Microbial imbalance and intestinal pathologies: connections and contributions. Dis Model Mech. 2014;7:1131-1142. [PMID: 25256712 DOI: 10.1242/dmm.016428] [Cited by in Crossref: 62] [Cited by in F6Publishing: 55] [Article Influence: 8.9] [Reference Citation Analysis]
108 Law ST, Li KK. Gender-related differences in clinical course of crohn?s disease in an Asian population: a retrospective cohort review. Arq Gastroenterol 2014;51:90-6. [PMID: 25003258 DOI: 10.1590/s0004-28032014000200004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
109 Lee HS, Park SH, Yang SK, Kim SO, Soh JS, Lee S, Bae JH, Lee HJ, Yang DH, Kim KJ, Ye BD, Byeon JS, Myung SJ, Kim JH. Appendectomy and the clinical course of ulcerative colitis: a retrospective cohort study and a nested case-control study from Korea. J Gastroenterol Hepatol 2015;30:470-7. [PMID: 25159898 DOI: 10.1111/jgh.12707] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
110 Ng SC, Tang W, Ching JY, Wong M, Chow CM, Hui A, Wong T, Leung VK, Tsang SW, Yu HH, Li MF, Ng KK, Kamm MA, Studd C, Bell S, Leong R, de Silva HJ, Kasturiratne A, Mufeena M, Ling KL, Ooi CJ, Tan PS, Ong D, Goh KL, Hilmi I, Pisespongsa P, Manatsathit S, Rerknimitr R, Aniwan S, Wang YF, Ouyang Q, Zeng Z, Zhu Z, Chen MH, Hu PJ, Wu K, Wang X, Simadibrata M, Abdullah M, Wu JC, Sung JJ, Chan FK. Incidence and Phenotype of Inflammatory Bowel Disease Based on Results From the Asia-Pacific Crohn's and Colitis Epidemiology Study. Gastroenterology 2013;145:158-165.e2. [DOI: 10.1053/j.gastro.2013.04.007] [78495111110.1053/j.gastro.2013.04.007','', '1007-9327')">Reference Citation Analysis]
111 Lean QY, Gueven N, Eri RD, Bhatia R, Sohal SS, Stewart N, Peterson GM, Patel RP. Heparins in ulcerative colitis: proposed mechanisms of action and potential reasons for inconsistent clinical outcomes. Expert Rev Clin Pharmacol 2015;8:795-811. [PMID: 26308504 DOI: 10.1586/17512433.2015.1082425] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
112 Chan SN, Low END, Raja Ali RA, Mokhtar NM. Delineating inflammatory bowel disease through transcriptomic studies: current review of progress and evidence. Intest Res 2018;16:374-83. [PMID: 30090036 DOI: 10.5217/ir.2018.16.3.374] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
113 Lee JY, Oh K, Hong HS, Kim K, Hong SW, Park JH, Hwang SW, Yang DH, Ye BD, Byeon JS, Myung SJ, Yang SK, Lee HS, Jo KW, Park SH. Risk and characteristics of tuberculosis after anti-tumor necrosis factor therapy for inflammatory bowel disease: a hospital-based cohort study from Korea. BMC Gastroenterol 2021;21:390. [PMID: 34670529 DOI: 10.1186/s12876-021-01973-5] [Reference Citation Analysis]
114 Farzaei MH, Bahramsoltani R, Abdolghaffari AH, Sodagari HR, Esfahani SA, Rezaei N. A mechanistic review on plant-derived natural compounds as dietary supplements for prevention of inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2016;10:745-758. [PMID: 26799847 DOI: 10.1586/17474124.2016.1145546] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
115 Prideaux L, Kamm MA, De Cruz P, van Langenberg DR, Ng SC, Dotan I. Inflammatory bowel disease serology in Asia and the West. World J Gastroenterol 2013; 19(37): 6207-6213 [PMID: 24115818 DOI: 10.3748/wjg.v19.i37.6207] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
116 Park HJ, Jung ES, Kong KA, Park EM, Cheon JH, Choi JH. Identification of OCTN2 variants and their association with phenotypes of Crohn's disease in a Korean population. Sci Rep 2016;6:22887. [PMID: 26965072 DOI: 10.1038/srep22887] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
117 Mao F, Kang JJ, Cai X, Ding NF, Wu YB, Yan YM, Qian H, Zhang X, Xu WR. Crosstalk between mesenchymal stem cells and macrophages in inflammatory bowel disease and associated colorectal cancer. Contemp Oncol (Pozn) 2017;21:91-7. [PMID: 28947877 DOI: 10.5114/wo.2017.68616] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
118 de Silva P, Korzenik J. The changing epidemiology of inflammatory bowel disease: identifying new high-risk populations. Clin Gastroenterol Hepatol 2015;13:690-2. [PMID: 25451560 DOI: 10.1016/j.cgh.2014.11.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
119 Chan HC, Wong VW, Wong GL, Tang W, Wu JC, Ng SC. Prevalence of hepatitis B and clinical outcomes in inflammatory bowel disease patients in a viral-endemic region. BMC Gastroenterol. 2016;16:100. [PMID: 27549153 DOI: 10.1186/s12876-016-0516-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
120 Yen HH, Weng MT, Tung CC, Wang YT, Chang YT, Chang CH, Shieh MJ, Wong JM, Wei SC. Epidemiological trend in inflammatory bowel disease in Taiwan from 2001 to 2015: a nationwide populationbased study. Intest Res 2019;17:54-62. [PMID: 30449079 DOI: 10.5217/ir.2018.00096] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 9.0] [Reference Citation Analysis]
121 Dolan KT, Chang EB. Diet, gut microbes, and the pathogenesis of inflammatory bowel diseases. Mol Nutr Food Res 2017;61. [PMID: 27346644 DOI: 10.1002/mnfr.201600129] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 8.3] [Reference Citation Analysis]
122 Niriella MA, Liyanage IK, Kodisinghe SK, De Silva AP, Jayatissa AVGAM, Navarathne NMM, Peiris RK, Kalubovila UP, Kumarasena SR, Jayasekara RW, de Silva HJ. Changing phenotype, early clinical course and clinical predictors of inflammatory bowel disease in Sri Lanka: a retrospective, tertiary care-based, multi-centre study. BMC Gastroenterol 2021;21:71. [PMID: 33593289 DOI: 10.1186/s12876-021-01644-5] [Reference Citation Analysis]
123 Takahashi H, Matsui T, Hisabe T, Hirai F, Takatsu N, Tsurumi K, Kanemitsu T, Sato Y, Kinjyo K, Yano Y, Takaki Y, Nagahama T, Yao K, Washio M. Second peak in the distribution of age at onset of ulcerative colitis in relation to smoking cessation. J Gastroenterol Hepatol. 2014;29:1603-1608. [PMID: 24731020 DOI: 10.1111/jgh.12616] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
124 Puri AS. Epidemiology of Ulcerative Colitis in South Asia. Intest Res 2013;11:250. [DOI: 10.5217/ir.2013.11.4.250] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
125 Pashazadeh P, Marjani A, Asadi J, Khoshnia M. Thiopurine Methyltransferase Genetic Polymorphisms and Activity and Metabolic Products of Azathioprine in Patients with Inflammatory Bowel Disease. Endocr Metab Immune Disord Drug Targets 2019;19:541-7. [PMID: 30451123 DOI: 10.2174/1871530318666181119153522] [Reference Citation Analysis]
126 Xiao Z, Pei Z, Yuan M, Li X, Chen S, Xu L. Risk of Stroke in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Journal of Stroke and Cerebrovascular Diseases 2015;24:2774-80. [DOI: 10.1016/j.jstrokecerebrovasdis.2015.08.008] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
127 Hein R, Köster I, Bollschweiler E, Schubert I. Prevalence of inflammatory bowel disease: estimates for 2010 and trends in Germany from a large insurance-based regional cohort. Scandinavian Journal of Gastroenterology 2014;49:1325-35. [DOI: 10.3109/00365521.2014.962605] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
128 Meima-van Praag EM, Buskens CJ, Hompes R, Bemelman WA. Surgical management of Crohn's disease: a state of the art review. Int J Colorectal Dis 2021;36:1133-45. [PMID: 33528750 DOI: 10.1007/s00384-021-03857-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
129 Park S, Wong Z, Park SH, Vu KV, Bang KB, Piyachaturawat P, Myint T, Hilmi I, Park D. Extraintestinal manifestation of inflammatory bowel disease in Asian patients: A multinational study. Digestive and Liver Disease 2021;53:196-201. [DOI: 10.1016/j.dld.2020.06.046] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
130 Zhang J, Gao F. Value of interferon-γ release assay and polymerase chain reaction for Mycobacterium tuberculosis in differentiation of intestinal tuberculosis from Crohn's disease. Shijie Huaren Xiaohua Zazhi 2014; 22(4): 527-532 [DOI: 10.11569/wcjd.v22.i4.527] [Reference Citation Analysis]
131 Shi HY, Chan FK, Tsang SW, Hui YT, Sze SF, Ching JY, Chung T, Iu CY, Lo FH, Shan EH, Li MK, Wu JC, Sung JJ, Ng SC. Factors associated with mucosal healing in patients with ulcerative colitis in clinical remission. Inflamm Bowel Dis 2015;21:840-6. [PMID: 25738375 DOI: 10.1097/MIB.0000000000000334] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
132 Sakai K, Sakurai T, De Velasco MA, Nagai T, Chikugo T, Ueshima K, Kura Y, Takahama T, Hayashi H, Nakagawa K, Kudo M, Nishio K. Intestinal Microbiota and Gene Expression Reveal Similarity and Dissimilarity Between Immune-Mediated Colitis and Ulcerative Colitis. Front Oncol 2021;11:763468. [PMID: 34778085 DOI: 10.3389/fonc.2021.763468] [Reference Citation Analysis]
133 Li J, Lyu H, Yang H, Li Y, Tan B, Wei MM, Sun XY, Li JN, Wu B, Qian JM. Preoperative Corticosteroid Usage and Hypoalbuminemia Increase Occurrence of Short-term Postoperative Complications in Chinese Patients with Ulcerative Colitis. Chin Med J (Engl) 2016;129:435-41. [PMID: 26879017 DOI: 10.4103/0366-6999.176072] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
134 Wu H, Rao Q, Ma GC, Yu XH, Zhang CE, Ma ZJ. Effect of Triptolide on Dextran Sodium Sulfate-Induced Ulcerative Colitis and Gut Microbiota in Mice. Front Pharmacol 2019;10:1652. [PMID: 32063856 DOI: 10.3389/fphar.2019.01652] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
135 Choi YY, Lee JK, Kim HS, Kim DW, Kim HM, Kang DR. Medications and the Risk of Colorectal Cancer in Patients with Inflammatory Bowel Diseases: Use of the Landmark Method. Yonsei Med J 2021;62:997-1004. [PMID: 34672133 DOI: 10.3349/ymj.2021.62.11.997] [Reference Citation Analysis]
136 Soni D, Salh B. A neutraceutical by design: the clinical application of curcumin in colonic inflammation and cancer. Scientifica (Cairo) 2012;2012:757890. [PMID: 24278738 DOI: 10.6064/2012/757890] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
137 Yoon YS, Cho YB, Park KJ, Baik SH, Yoon SN, Ryoo SB, Lee KY, Kim H, Lee RA, Group CSYIS, Coloproctology KSO. Surgical outcomes of Korean ulcerative colitis patients with and without colitis-associated cancer. World J Gastroenterol 2015; 21(12): 3547-3553 [PMID: 25834319 DOI: 10.3748/wjg.v21.i12.3547] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
138 Wei SC, Chang TA, Chao TH, Chen JS, Chou JW, Chou YH, Chuang CH, Hsu WH, Huang TY, Hsu TC, Lin CC, Lin HH, Lin JK, Lin WC, Ni YH, Shieh MJ, Shih IL, Shun CT, Tsang YM, Wang CY, Wang HY, Weng MT, Wu DC, Wu WC, Yen HH, Wong JM. Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease.Intest Res. 2017;15:266-284. [PMID: 28670225 DOI: 10.5217/ir.2017.15.3.266] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
139 Wu KC, Ran ZH, Gao X, Chen M, Zhong J, Sheng JQ, Kamm MA, Travis S, Wallace K, Mostafa NM, Shapiro M, Li Y, Thakkar RB, Robinson AM. Adalimumab induction and maintenance therapy achieve clinical remission and response in Chinese patients with Crohn's disease. Intest Res 2016;14:152-63. [PMID: 27175116 DOI: 10.5217/ir.2016.14.2.152] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
140 Rahimian R, Zirak MR, Keshavarz M, Fakhraei N, Mohammadi-farani A, Hamdi H, Mousavizadeh K. Involvement of PPAR γ in the protective action of tropisetron in an experimental model of ulcerative colitis. Immunopharmacology and Immunotoxicology 2016;38:432-40. [DOI: 10.1080/08923973.2016.1231202] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
141 Wei SC, Lin MH, Tung CC, Weng MT, Kuo JS, Shieh MJ, Wang CY, Ho WC, Wong JM, Chen PC. A nationwide population-based study of the inflammatory bowel diseases between 1998 and 2008 in Taiwan. BMC Gastroenterol. 2013;13:166. [PMID: 24314308 DOI: 10.1186/1471-230x-13-166] [Cited by in Crossref: 44] [Cited by in F6Publishing: 21] [Article Influence: 4.9] [Reference Citation Analysis]
142 Sung MK, Park MY. Nutritional modulators of ulcerative colitis: Clinical efficacies and mechanistic view. World J Gastroenterol 2013; 19(7): 994-1004 [PMID: 23467687 DOI: 10.3748/wjg.v19.i7.994] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
143 Dou W, Zhang J, Ren G, Ding L, Sun A, Deng C, Wu X, Wei X, Mani S, Wang Z. Mangiferin attenuates the symptoms of dextran sulfate sodium-induced colitis in mice via NF-κB and MAPK signaling inactivation. Int Immunopharmacol 2014;23:170-8. [PMID: 25194678 DOI: 10.1016/j.intimp.2014.08.025] [Cited by in Crossref: 81] [Cited by in F6Publishing: 79] [Article Influence: 10.1] [Reference Citation Analysis]
144 Chen B, Gao X, Zhong J, Ren J, Zhu X, Liu Z, Wu K, Kalabic J, Yu Z, Huang B, Kwatra N, Doan T, Robinson AM, Chen MH. Efficacy and safety of adalimumab in Chinese patients with moderately to severely active Crohn's disease: results from a randomized trial. Therap Adv Gastroenterol 2020;13:1756284820938960. [PMID: 32733600 DOI: 10.1177/1756284820938960] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
145 Liu Y, Ye Q, Liu YL, Kang J, Chen Y, Dong WG. Schistosoma japonicum attenuates dextran sodium sulfate-induced colitis in mice via reduction of endoplasmic reticulum stress. World J Gastroenterol 2017; 23(31): 5700-5712 [PMID: 28883695 DOI: 10.3748/wjg.v23.i31.5700] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
146 Kita T, Kaji Y, Kitamura K. Safety, Tolerability, and Pharmacokinetics of Adrenomedullin in Healthy Males: A Randomized, Double-Blind, Phase 1 Clinical Trial. Drug Des Devel Ther 2020;14:1-11. [PMID: 32021087 DOI: 10.2147/DDDT.S225220] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
147 Jiang M, Gao HL, Yao P. Quantification of intestinal microflora in ulcerative colitis patients using real-time PCR. Shijie Huaren Xiaohua Zazhi 2014; 22(4): 596-600 [DOI: 10.11569/wcjd.v22.i4.596] [Cited by in CrossRef: 1] [Article Influence: 0.1] [Reference Citation Analysis]
148 Lee WS, Ng RT, Chan KW, Lau YL. Variable outcome in infantile-onset inflammatory bowel disease in an Asian cohort. World J Gastroenterol 2016; 22(48): 10653-10662 [PMID: 28082818 DOI: 10.3748/wjg.v22.i48.10653] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
149 Hisamatsu T, Erben U, Kühl AA. The Role of T-Cell Subsets in Chronic Inflammation in Celiac Disease and Inflammatory Bowel Disease Patients: More Common Mechanisms or More Differences? Inflamm Intest Dis 2016;1:52-62. [PMID: 29922658 DOI: 10.1159/000445133] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
150 Bandyopadhyay D, Bandyopadhyay S, Ghosh P, De A, Bhattacharya A, Dhali GK, Das K. Extraintestinal manifestations in inflammatory bowel disease: Prevalence and predictors in Indian patients. Indian J Gastroenterol. 2015;34:387-394. [PMID: 26614005 DOI: 10.1007/s12664-015-0598-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
151 Jin B. Fecal microbiota transplantation in ulcerative colitis. Shijie Huaren Xiaohua Zazhi 2017; 25(1): 23-30 [DOI: 10.11569/wcjd.v25.i1.23] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
152 Kang SH, Jeon YD, Moon KH, Lee JH, Kim DG, Kim W, Myung H, Kim JS, Kim HJ, Bang KS, Jin JS. Aronia Berry Extract Ameliorates the Severity of Dextran Sodium Sulfate-Induced Ulcerative Colitis in Mice. J Med Food. 2017;20:667-675. [PMID: 28677983 DOI: 10.1089/jmf.2016.3822] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
153 Martins KR, Araújo JM, Cruz ÁC, Luiz-Ferreira A. EPIDEMIOLOGIC ASPECTS OF INFLAMMATORY BOWEL DISEASE IN THE WESTERN REGION OF MINAS GERAIS STATE. Arq Gastroenterol 2021;58:377-83. [PMID: 34705974 DOI: 10.1590/S0004-2803.202100000-63] [Reference Citation Analysis]
154 Ning L, Shan G, Sun Z, Zhang F, Xu C, Lou X, Li S, Du H, Chen H, Xu G. Quantitative Proteomic Analysis Reveals the Deregulation of Nicotinamide Adenine Dinucleotide Metabolism and CD38 in Inflammatory Bowel Disease. Biomed Res Int. 2019;2019:3950628. [PMID: 31179321 DOI: 10.1155/2019/3950628] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
155 Dranga M, Boiculese LV, Popa IV, Floria M, Gavril OI, Bărboi OB, Trifan A, Cijevschi Prelipcean C, Mihai C, Gavrilescu O. Anemia in Crohn's Disease-The Unseen Face of Inflammatory Bowel Disease. Medicina (Kaunas) 2021;57:1046. [PMID: 34684083 DOI: 10.3390/medicina57101046] [Reference Citation Analysis]
156 Chen J, Ren J, Gu G, Wang G, Wu X, Yan D, Liu S, Li J. Crohn’s disease and polymorphism of heat shock protein gene HSP70-2 in the Chinese population. J Gastroenterol Hepatol. 2013;28:814-818. [PMID: 23425104 DOI: 10.1111/jgh.12163] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
157 Hibi T, Ishibashi T, Ikenoue Y, Yoshihara R, Nihei A, Kobayashi T. Ulcerative Colitis: Disease Burden, Impact on Daily Life, and Reluctance to Consult Medical Professionals: Results from a Japanese Internet Survey. Inflamm Intest Dis 2020;5:27-35. [PMID: 32232052 DOI: 10.1159/000505092] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
158 Bernstein CN, Eliakim A, Fedail S, Fried M, Gearry R, Goh KL, Hamid S, Khan AG, Khalif I, Ng SC, Ouyang Q, Rey JF, Sood A, Steinwurz F, Watermeyer G, LeMair A; Review Team:. World Gastroenterology Organisation Global Guidelines Inflammatory Bowel Disease: Update August 2015. J Clin Gastroenterol. 2016;50:803-818. [PMID: 27741097 DOI: 10.1097/mcg.0000000000000660] [Cited by in Crossref: 52] [Cited by in F6Publishing: 24] [Article Influence: 13.0] [Reference Citation Analysis]
159 Kawalec P, Pilc A. An indirect comparison of infliximab versus adalimumab or golimumab for active ulcerative colitis. Arch Med Sci 2016;12:1097-109. [PMID: 27695502 DOI: 10.5114/aoms.2016.58682] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
160 Larsson G, Shenoy T, Ramasubramanian R, Balakumaran LK, Småstuen MC, Bjune GA, Moum BA. Routine diagnosis of intestinal tuberculosis and Crohn's disease in Southern India. World J Gastroenterol 2014; 20(17): 5017-5024 [PMID: 24803814 DOI: 10.3748/wjg.v20.i17.5017] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
161 Leung WK. Optimization of Inflammatory Bowel Disease Cohort Studies in Asia. Intest Res 2015;13:208-12. [PMID: 26130994 DOI: 10.5217/ir.2015.13.3.208] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
162 Mesbah-Uddin M, Elango R, Banaganapalli B, Shaik NA, Al-Abbasi FA. In-silico analysis of inflammatory bowel disease (IBD) GWAS loci to novel connections. PLoS One 2015;10:e0119420. [PMID: 25786114 DOI: 10.1371/journal.pone.0119420] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
163 Banerjee R, Chuah SW, Hilmi IN, Wu DC, Yang SK, Demuth D, Lindner D, Adsul S. Efficacy and safety of vedolizumab in Crohn's disease in patients from Asian countries in the GEMINI 2 study. Intest Res 2021;19:83-94. [PMID: 33378612 DOI: 10.5217/ir.2019.09160] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
164 崔旻, 谭芳, 王海昆, 姚萍, 谭庆华. 新疆维吾尔族和汉族溃疡性结肠炎患者IL-23R基因多态性的初步研究. 世界华人消化杂志 2017; 25(23): 2109-2116 [DOI: 10.11569/wcjd.v25.i23.2109] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
165 Bitton A, Vutcovici M, Patenaude V, Sewitch M, Suissa S, Brassard P. Epidemiology of inflammatory bowel disease in Québec: recent trends. Inflamm Bowel Dis 2014;20:1770-6. [PMID: 25159452 DOI: 10.1097/MIB.0000000000000162] [Cited by in Crossref: 44] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
166 Takewaki D, Suda W, Sato W, Takayasu L, Kumar N, Kimura K, Kaga N, Mizuno T, Miyake S, Hattori M, Yamamura T. Alterations of the gut ecological and functional microenvironment in different stages of multiple sclerosis. Proc Natl Acad Sci U S A 2020;117:22402-12. [PMID: 32839304 DOI: 10.1073/pnas.2011703117] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 17.0] [Reference Citation Analysis]
167 Rajbhandari R, Blakemore S, Gupta N, Adler AJ, Noble CA, Mannan S, Nikolli K, Yih A, Joshi S, Bukhman G. Crohn’s disease in low and lower-middle income countries: A scoping review. World J Gastroenterol 2020; 26(43): 6891-6908 [PMID: 33268969 DOI: 10.3748/wjg.v26.i43.6891] [Cited by in CrossRef: 1] [Article Influence: 0.5] [Reference Citation Analysis]
168 Kawalec P, Mikrut A, Łopuch S. Systematic review of the effectiveness of biological therapy for active moderate to severe ulcerative colitis: Biological therapy for ulcerative colitis. J Gastroenterol Hepatol 2014;29:1159-70. [DOI: 10.1111/jgh.12563] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
169 Piao X, Liu B, Guo L, Meng F, Gao L. Picroside II Shows Protective Functions for Severe Acute Pancreatitis in Rats by Preventing NF-κB-Dependent Autophagy. Oxid Med Cell Longev 2017;2017:7085709. [PMID: 28713490 DOI: 10.1155/2017/7085709] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
170 Figueroa C. Epidemiología de la enfermedad inflamatoria intestinal. Revista Médica Clínica Las Condes 2019;30:257-61. [DOI: 10.1016/j.rmclc.2019.06.003] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
171 Wang L, Xie M, Hong L, Zhang C, Zhang T, Fan R, Zhong J, Wang Z. The Diagnostic Yields and Safety of Double-Balloon Enteroscopy in Obscure Gastrointestinal Bleeding and Incomplete Small Bowel Obstruction: Comparison between the Adults and Elderly. Gastroenterol Res Pract 2020;2020:8121625. [PMID: 32411202 DOI: 10.1155/2020/8121625] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
172 Colman RJ, Dhaliwal J, Rosen MJ. Predicting Therapeutic Response in Pediatric Ulcerative Colitis-A Journey Towards Precision Medicine. Front Pediatr 2021;9:634739. [PMID: 33681110 DOI: 10.3389/fped.2021.634739] [Reference Citation Analysis]
173 Hsu WF, Wu CS, Wu JM, Chung CS. Ileal Crohn's disease with perforation misdiagnosed as ruptured appendicitis: a case report. J Formos Med Assoc 2013;112:652-3. [PMID: 23962876 DOI: 10.1016/j.jfma.2013.07.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
174 Sharara AI, Al Awadhi S, Alharbi O, Al Dhahab H, Mounir M, Salese L, Singh E, Sunna N, Tarcha N, Mosli M. Epidemiology, disease burden, and treatment challenges of ulcerative colitis in Africa and the Middle East. Expert Rev Gastroenterol Hepatol. 2018;12:883-897. [PMID: 30096985 DOI: 10.1080/17474124.2018.1503052] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
175 Duan H, Lü S, Gao C, Bai X, Qin H, Wei Y, Wu X, Liu M. Mucoadhesive microparticulates based on polysaccharide for target dual drug delivery of 5-aminosalicylic acid and curcumin to inflamed colon. Colloids Surf B Biointerfaces 2016;145:510-9. [PMID: 27239905 DOI: 10.1016/j.colsurfb.2016.05.038] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
176 Albanese D, De Filippo C, Cavalieri D, Donati C. Explaining diversity in metagenomic datasets by phylogenetic-based feature weighting. PLoS Comput Biol 2015;11:e1004186. [PMID: 25815895 DOI: 10.1371/journal.pcbi.1004186] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
177 Okaniwa N, Sasaki M, Mizushima T, Ogasawara N, Funaki Y, Joh T, Kasugai K. eNOS plays an important role in the regulation of colonic inflammation: a novel therapeutic target and a predictive marker for the prognosis of ulcerative colitis. Free Radic Res 2015;49:35-44. [PMID: 25329334 DOI: 10.3109/10715762.2014.977788] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
178 Yoshizawa K, Joshita S, Matsumoto A, Umemura T, Tanaka E, Morita S, Maejima T, Ota M. Incidence and prevalence of autoimmune hepatitis in the Ueda area, Japan. Hepatol Res. 2016;46:878-883. [PMID: 26670542 DOI: 10.1111/hepr.12639] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
179 Malekzadeh MM, Sima A, Alatab S, Sadeghi A, Daryani NE, Adibi P, Maleki I, Vossoughinia H, Fakheri H, Yazdanbod A, Taghavi SA, Aghazadeh R, Somi MH, Zendedel K, Vahedi H, Malekzadeh R. Iranian Registry of Crohn's and Colitis: study profile of first nation-wide inflammatory bowel disease registry in Middle East. Intest Res 2019;17:330-9. [PMID: 31006228 DOI: 10.5217/ir.2018.00157] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
180 Maataoui A, Vogl TJ, Jacobi V, Khan MF. Enteroclysis: Current clinical value. World J Radiol 2013; 5(7): 253-258 [PMID: 23908695 DOI: 10.4329/wjr.v5.i7.253] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
181 Suchecka D, Harasym J, Wilczak J, Gajewska M, Oczkowski M, Gudej S, Błaszczyk K, Kamola D, Filip R, Gromadzka-ostrowska J. Antioxidative and anti-inflammatory effects of high beta-glucan concentration purified aqueous extract from oat in experimental model of LPS-induced chronic enteritis. Journal of Functional Foods 2015;14:244-54. [DOI: 10.1016/j.jff.2014.12.019] [Cited by in Crossref: 27] [Cited by in F6Publishing: 12] [Article Influence: 3.9] [Reference Citation Analysis]
182 Wang ZK, Yang YS, Chen Y, Yuan J, Sun G, Peng LH. Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease. World J Gastroenterol 2014; 20(40): 14805-14820 [PMID: 25356041 DOI: 10.3748/wjg.v20.i40.14805] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 50] [Article Influence: 7.5] [Reference Citation Analysis]
183 Kobayashi T, Uda A, Udagawa E, Hibi T. Lack of Increased Risk of Lymphoma by Thiopurines or Biologics in Japanese Patients with Inflammatory Bowel Disease: A Large-Scale Administrative Database Analysis. J Crohns Colitis 2020;14:617-23. [PMID: 31867632 DOI: 10.1093/ecco-jcc/jjz204] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
184 Zhao Y, Xu M, Chen L, Liu Z, Sun X. Levels of TB-IGRA may help to differentiate between intestinal tuberculosis and Crohn's disease in patients with positive results. Therap Adv Gastroenterol 2020;13:1756284820922003. [PMID: 32523624 DOI: 10.1177/1756284820922003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
185 Bashashati M, Rezaei N, Bashashati H, Shafieyoun A, Daryani NE, Sharkey KA, Storr M. Cytokine gene polymorphisms are associated with irritable bowel syndrome: a systematic review and meta-analysis. Neurogastroenterol Motil. 2012;24:1102-e566. [PMID: 22897390 DOI: 10.1111/j.1365-2982.2012.01990.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
186 Hwang SW, Seo H, Kim GU, Song EM, Seo M, Park SH, Kwon E, Lee HS, Yang DH, Kim KJ, Ye BD, Byeon JS, Myung SJ, Kim JH, Yang SK. Underestimation of Smoking Rates in an East Asian Population with Crohn's Disease. Gut Liver 2017;11:73-8. [PMID: 27728967 DOI: 10.5009/gnl16194] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
187 Tyagi A, Kumar U, Santosh VS, Reddy S, Mohammed SB, Ibrahim A. Partial replacement of dietary linoleic acid with long chain n-3 polyunsaturated fatty acids protects against dextran sulfate sodium-induced colitis in rats. Prostaglandins, Leukotrienes and Essential Fatty Acids 2014;91:289-97. [DOI: 10.1016/j.plefa.2014.09.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
188 Nakase H, Keum B, Ye BD, Park SJ, Koo HS, Eun CS. Treatment of inflammatory bowel disease in Asia: The results of a multinational web-based survey in the 2(nd) Asian Organization of Crohn's and Colitis (AOCC) meeting in Seoul. Intest Res. 2016;14:231-239. [PMID: 27433145 DOI: 10.5217/ir.2016.14.3.231] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
189 Ng SC, Tang W, Ching JY, Wong M, Chow CM, Hui AJ, Wong TC, Leung VK, Tsang SW, Yu HH, Li MF, Ng KK, Kamm MA, Studd C, Bell S, Leong R, de Silva HJ, Kasturiratne A, Mufeena MNF, Ling KL, Ooi CJ, Tan PS, Ong D, Goh KL, Hilmi I, Pisespongsa P, Manatsathit S, Rerknimitr R, Aniwan S, Wang YF, Ouyang Q, Zeng Z, Zhu Z, Chen MH, Hu PJ, Wu K, Wang X, Simadibrata M, Abdullah M, Wu JC, Sung JJY, Chan FKL; Asia-Pacific Crohn's and Colitis Epidemiologic Study (ACCESS) Study Group. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study. Gastroenterology. 2013;145:158-165. [PMID: 23583432 DOI: 10.1053/j.gastro.2013.04.007] [Cited by in Crossref: 413] [Cited by in F6Publishing: 390] [Article Influence: 45.9] [Reference Citation Analysis]
190 Chi-lun Leung Y, Man-yee Tang P, Shih-yin Chao N, Wai-yip Leung M. Perianastomotic ulceration in children with short bowel syndrome. Journal of Pediatric Surgery Case Reports 2022;81:102285. [DOI: 10.1016/j.epsc.2022.102285] [Reference Citation Analysis]
191 Loukas A, Hotez PJ, Diemert D, Yazdanbakhsh M, McCarthy JS, Correa-Oliveira R, Croese J, Bethony JM. Hookworm infection. Nat Rev Dis Primers 2016;2:16088. [PMID: 27929101 DOI: 10.1038/nrdp.2016.88] [Cited by in Crossref: 91] [Cited by in F6Publishing: 79] [Article Influence: 15.2] [Reference Citation Analysis]
192 Lu CY, Ni YH. Gut microbiota and the development of pediatric diseases. J Gastroenterol 2015;50:720-6. [PMID: 25917564 DOI: 10.1007/s00535-015-1082-z] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
193 Danese S, Banerjee R, Cummings JF, Dotan I, Kotze PG, Leong RWL, Paridaens K, Peyrin-Biroulet L, Scott G, Assche GV, Wehkamp J, Yamamoto-Furusho JK. Consensus recommendations for patient-centered therapy in mild-to-moderate ulcerative colitis: the i Support Therapy-Access to Rapid Treatment (iSTART) approach. Intest Res 2018;16:522-8. [PMID: 30321913 DOI: 10.5217/ir.2018.00073] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
194 Pandey A, Salazar E, Kong CSC, Lim WC, Ong J, Ong DEH, Ong C, Aw M, Wee E, Chuah SW, Tan V, Tay WL, Nadkarni N, Ling KL. Risk of Major Abdominal Surgery in an Asian Population-based Crohnʼs Disease Cohort: . Inflammatory Bowel Diseases 2015;21:2625-33. [DOI: 10.1097/mib.0000000000000525] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
195 Yi F, Chen M, Huang M, Li J, Zhao J, Li L, Xia B. The trend in newly diagnosed Crohn’s disease and extraintestinal manifestations of Crohn’s disease in central China: a retrospective study of a single center. Eur J Gastroenterol Hepatol. 2012;24:1424-1429. [PMID: 22895389 DOI: 10.1097/meg.0b013e3283583e5c] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
196 Friedman A, Gibson P. Inflammatory Bowel Disease – Crohn's Disease and Ulcerative Colitis. Reference Module in Biomedical Sciences. Elsevier; 2014. [DOI: 10.1016/b978-0-12-801238-3.00052-0] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
197 Bak YK, Lampe JW, Sung MK. Effects of dietary supplementation of glucosamine sulfate on intestinal inflammation in a mouse model of experimental colitis. J Gastroenterol Hepatol. 2014;29:957-963. [PMID: 24325781 DOI: 10.1111/jgh.12485] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
198 Lovasz BD, Golovics PA, Vegh Z, Lakatos PL. New trends in inflammatory bowel disease epidemiology and disease course in Eastern Europe. Dig Liver Dis. 2013;45:269-276. [PMID: 23010518 DOI: 10.1016/j.dld.2012.08.020] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
199 Lee Y, Lee J, Ju J. Perilla frutescens Britton var. frutescens leaves attenuate dextran sulfate sodium-induced acute colitis in mice and lipopolysaccharide-stimulated angiogenic processes in human umbilical vein endothelial cells. Food Sci Biotechnol 2020;29:131-40. [PMID: 31976135 DOI: 10.1007/s10068-019-00711-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
200 da Silva BC, Lyra AC, Rocha R, Santana GO. Epidemiology, demographic characteristics and prognostic predictors of ulcerative colitis. World J Gastroenterol 2014;20:9458-67. [PMID: 25071340 DOI: 10.3748/wjg.v20.i28.9458] [Cited by in CrossRef: 133] [Cited by in F6Publishing: 113] [Article Influence: 16.6] [Reference Citation Analysis]
201 Kobayashi T, Hisamatsu T, Suzuki Y, Ogata H, Andoh A, Araki T, Hokari R, Iijima H, Ikeuchi H, Ishiguro Y, Kato S, Kunisaki R, Matsumoto T, Motoya S, Nagahori M, Nakamura S, Nakase H, Tsujikawa T, Sasaki M, Yokoyama K, Yoshimura N, Watanabe K, Katafuchi M, Watanabe M, Hibi T. Predicting outcomes to optimize disease management in inflammatory bowel disease in Japan: their differences and similarities to Western countries. Intest Res 2018;16:168-77. [PMID: 29743830 DOI: 10.5217/ir.2018.16.2.168] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
202 Connelly TM, Koltun WA. Inflammatory Bowel Disease: Pathobiology. In: Steele SR, Hull TL, Read TE, Saclarides TJ, Senagore AJ, Whitlow CB, editors. The ASCRS Textbook of Colon and Rectal Surgery. Cham: Springer International Publishing; 2016. pp. 749-69. [DOI: 10.1007/978-3-319-25970-3_44] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
203 Ponder A, Long MD. A clinical review of recent findings in the epidemiology of inflammatory bowel disease. Clin Epidemiol. 2013;5:237-247. [PMID: 23922506 DOI: 10.2147/clep.s33961] [Cited by in Crossref: 35] [Cited by in F6Publishing: 81] [Article Influence: 3.9] [Reference Citation Analysis]
204 Ong F, Seah Lee W, Lin C, Ng RT, Yee Wong S, Lim SL, Quak SH, Aw M. Complementary and alternative medicine (CAM) practices and dietary patterns in children with inflammatory bowel disease in Singapore and Malaysia. Pediatr Neonatol 2018;59:494-500. [PMID: 29352665 DOI: 10.1016/j.pedneo.2017.12.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
205 Low END, Mokhtar NM, Wong Z, Raja Ali RA. Colonic Mucosal Transcriptomic Changes in Patients with Long-Duration Ulcerative Colitis Revealed Colitis-Associated Cancer Pathways. J Crohns Colitis 2019;13:755-63. [PMID: 30954025 DOI: 10.1093/ecco-jcc/jjz002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
206 Byun JM, Lee CK, Rhee SY, Kim H, Im JP, Park DI, Eun CS, Jung S, Shin JE, Lee K, Cheon JH. Risks for opportunistic tuberculosis infection in a cohort of 873 patients with inflammatory bowel disease receiving a tumor necrosis factor-α inhibitor. Scandinavian Journal of Gastroenterology 2014;50:312-20. [DOI: 10.3109/00365521.2014.1000960] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
207 Gordon H, Trier Moller F, Andersen V, Harbord M. Heritability in inflammatory bowel disease: from the first twin study to genome-wide association studies. Inflamm Bowel Dis. 2015;21:1428-1434. [PMID: 25895112 DOI: 10.1097/mib.0000000000000393] [Cited by in Crossref: 13] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
208 Chan KJ, Song ZL, Chew KS, Ng RT, Mohd Taib SH, Lee WS. Exclusive enteral nutrition is effective and feasible as primary induction and re-induction therapy in Asian children with Crohn's disease. J Paediatr Child Health 2021;57:239-45. [PMID: 32936506 DOI: 10.1111/jpc.15184] [Reference Citation Analysis]
209 Higashiyama M, Sugita A, Koganei K, Wanatabe K, Yokoyama Y, Uchino M, Nagahori M, Naganuma M, Bamba S, Kato S, Takeuchi K, Omori T, Takagi T, Matsumoto S, Nagasaka M, Sagami S, Kitamura K, Katsurada T, Sugimoto K, Takatsu N, Saruta M, Sakurai T, Watanabe K, Nakamura S, Suzuki Y, Hokari R. Management of elderly ulcerative colitis in Japan. J Gastroenterol 2019;54:571-86. [PMID: 31025187 DOI: 10.1007/s00535-019-01580-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
210 Greuter T, Vavricka SR. Extraintestinal manifestations in inflammatory bowel disease – epidemiology, genetics, and pathogenesis. Expert Review of Gastroenterology & Hepatology 2019;13:307-17. [DOI: 10.1080/17474124.2019.1574569] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
211 Safarpour AR, Mehrabi M, Keshtkar A, Edjtehadi F, Bagheri Lankarani K. Systematic review and meta-analysis of the incidence and prevalence and 30-year trend of inflammatory bowel diseases in Asia: a study protocol. BMJ Open 2019;9:e031854. [PMID: 31748306 DOI: 10.1136/bmjopen-2019-031854] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]